Many further reports have suggested that the detection of anti-MOG antibodies in some patients was associated with a clinical syndrome different not only from MS, but from NMO as well, and in recent years, criteria of the new nosological entity of MOG-associated disease (MOGAD) have been postulated [17]. This evidence concerns the gene MOG and neuromyelitis optica.